Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

OCR Releases FAQ: Update to March 17 Telehealth Waiver Announcement

By Wakaba Tessier & Erica M. Ash on March 24, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

On March 20, 2020 OCR released a Frequently Asked Questions list to help further clarify its March 17th Waiver.  In the FAQ, OCR clarifies that the waiver not only allows providers to utilize platforms that do not comply with the requirements of the Security Rule (discussed in our original post), but it also applies to the Breach Notification and Privacy Rules that may be implicated when using a less secure platform. OCR also assures providers that if protected health information is intercepted and during the the “good faith provision of telehealth,” OCR will not pursue otherwise applicable penalties.

Also noted in our prior post, to benefit from the waiver providers must be engaged in the “good faith provision of telehealth during the COVID-19 nationwide public health emergency.”  Accordingly, providers that OCR determines are not providing telehealth services in good faith could be prosecuted. While this determination is made in light of all the facts and circumstances, OCR provides examples where it would likely not find the provider was acting in good faith.  These “bad faith” examples include: (i) using the platform to further an illegal act, (ii) further disclosing patient health information in violation of the Privacy Rule (e.g. using it for marketing without the patient’s prior authorization), (iii) violating state laws when providing the services (e.g. providing services without a license or applicable state waiver), and (iv) using a public facing platform to communicate with patients (e.g. TikTok or public chat room).  In sum, while the waiver gives healthcare providers the opportunity to continue to serve their patients during this outbreak, it should not be treated as a completely “free pass” and providers should be aware of its limits. If you have any questions, please contact one of our healthcare or privacy attorneys.

Review the full FAQ.

For more on COVID-19-related issues specific to healthcare providers and healthcare law, visit Husch Blackwell’s Healthcare Law Insights blog.

Photo of Wakaba Tessier Wakaba Tessier

Wakaba’s work requires mastery not just of the law but also the rapidly changing healthcare marketplace and its many regulations. She focuses on the unique issues faced by specialty pharmacies, such as licensing and other compliance challenges.

Email
Photo of Erica M. Ash Erica M. Ash

Erica helps healthcare clients navigate regulatory matters so they can get back to the business of patient care. She assists clients with compliance, transactional and licensure matters, including Health Insurance Portability and Accountability Act (HIPAA) compliance, Medicare and Medicaid reimbursement procedures, Stark Law

…

Erica helps healthcare clients navigate regulatory matters so they can get back to the business of patient care. She assists clients with compliance, transactional and licensure matters, including Health Insurance Portability and Accountability Act (HIPAA) compliance, Medicare and Medicaid reimbursement procedures, Stark Law compliance, and fraud, waste and abuse issues.

Email
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Byte Back
  • Organization:
    Husch Blackwell LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo